Efferon LPS Hemoperfusion for Treatment of Patients With Septic Shock

CompletedOBSERVATIONAL
Enrollment

9

Participants

Timeline

Start Date

September 13, 2019

Primary Completion Date

March 20, 2020

Study Completion Date

October 12, 2020

Conditions
Septic Shock
Interventions
DEVICE

Efferon LPS

Efferon LPS is a single-use therapeutic device for extracorporeal blood purification using direct hemoperfusion. Detoxification is carried out by selective adsorption of lipopolysaccharides (bacterial endotoxins) and non-selective removal of cytokines by internal porous structure. It is a cylindrical polycarbonate casing filled with spherical granules of LPS-selective polymeric adsorbent mesoporous beads and isotonic sodium chloride solution. The device is registered in Russia as a medical device RZN 2019/8886.

Trial Locations (1)

119049

N.I. Pirogov City Clinical Hospital No. 1, Moscow

All Listed Sponsors
lead

Efferon JSC

INDUSTRY

NCT04884854 - Efferon LPS Hemoperfusion for Treatment of Patients With Septic Shock | Biotech Hunter | Biotech Hunter